|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/12 Weikang Bio-Tech Group Co., Inc. 10-K 12/31/11 44:2.3M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 474K
2: EX-10.12 Material Contract HTML 15K
3: EX-14.1 Code of Ethics HTML 26K
4: EX-23.1 Consent of Experts or Counsel HTML 14K
5: EX-23.2 Consent of Experts or Counsel HTML 13K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
28: R1 Document and Entity Information HTML 45K
21: R2 Consolidated Balance Sheets HTML 128K
26: R3 Consolidated Balance Sheets (Parenthetical) HTML 25K
30: R4 Consolidated Statements of Income and HTML 99K
Comprehensive Income
41: R5 Consolidated Statements of Cash Flows HTML 111K
22: R6 Consolidated Statements of Stockholders' Equity HTML 64K
25: R7 Organization and Description of Business HTML 26K
20: R8 Summary of Significant Accounting Policies HTML 65K
18: R9 Accounts Receivable HTML 22K
42: R10 Advances to Suppliers and Other Receivables HTML 17K
32: R11 Inventory HTML 20K
31: R12 Property and Equipment, net HTML 23K
36: R13 Construction in Progress HTML 15K
37: R14 Intangible Assets HTML 21K
35: R15 Related Party Transactions HTML 20K
38: R16 Major Customers and Vendors HTML 15K
27: R17 Unearned Revenue HTML 18K
29: R18 Taxes Payable HTML 17K
34: R19 Other Payables and Accrued Expenses HTML 18K
44: R20 Deferred Tax Asset (Liability) HTML 19K
39: R21 Income Taxes HTML 26K
23: R22 Stockholders' Equity HTML 62K
33: R23 Statutory Reserves HTML 18K
24: R24 Contingencies HTML 16K
16: R25 Goodwill HTML 16K
40: R26 Subsequent Event HTML 16K
43: XML IDEA XML File -- Filing Summary XML 53K
19: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 212K
10: EX-101.INS XBRL Instance -- wkbt-20111231 XML 314K
12: EX-101.CAL XBRL Calculations -- wkbt-20111231_cal XML 105K
13: EX-101.DEF XBRL Definitions -- wkbt-20111231_def XML 300K
14: EX-101.LAB XBRL Labels -- wkbt-20111231_lab XML 341K
15: EX-101.PRE XBRL Presentations -- wkbt-20111231_pre XML 348K
11: EX-101.SCH XBRL Schema -- wkbt-20111231 XSD 60K
17: ZIP XBRL Zipped Folder -- 0001144204-12-018721-xbrl Zip 56K
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Weikang Bio-Technology Group Co., Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Baolin Sun, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
| Dated: March 30, 2012 | By: | /s/ Baolin Sun |
|
Chief Financial Officer |
C:
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/30/12 | None on these Dates | ||
| For Period end: | 12/31/11 | |||
| List all Filings | ||||